<DOC>
	<DOCNO>NCT00004338</DOCNO>
	<brief_summary>OBJECTIVES : I . Establish safety efficacy extend maintenance zinc therapy 200 patient Wilson disease . II . Establish role zinc prophylactic treatment presymptomatic patient increase current cohort 80 least 100 patient . III . Establish role zinc therapy pregnant patient Wilson disease . IV . Establish role zinc therapy child Wilson disease .</brief_summary>
	<brief_title>Study Zinc Wilson Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive copper regulation therapy zinc acetate : exist cohort maintenance therapy follow long-term data collection ; presymptomatic patient treat prophylactically ; pregnant patient evaluate fetal outcome . All patient evaluate copper balance , clinical control , toxicity .</detailed_description>
	<mesh_term>Hepatolenticular Degeneration</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Wilson disease Presymptomatic , pregnant , child 16 year young patient eligible Patient age : Any age , include child</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Wilson disease</keyword>
	<keyword>inborn error metabolism</keyword>
	<keyword>rare disease</keyword>
</DOC>